Acceptable standards of medical and surgical diagnosis and treatment depend upon the ready availability of high capacity chemical analysis. This need is expanding and there are valid reasons for believing that it will continue to do so. The present and future needs arise from clinical problems. The efflorescence of clinical chemistry during the past two decades has resulted from these problems and not from autonomous growth which then stimulated further demands from the bedside. The application of chemistry to medicine presents special problems in the fields of: (I) data interpretation, (2) data handling, (3) the need to incorporate a wide ranging consultative function into the system. Adaptability as well as new instruments will be needed in laboratory and clinical practice if we are to meet our patient's needs as clinicians and as laboratory workers.
The amount of work performed in Departments of Clinical Chemistry has been growing exponentially for the past 50 years, doubling every four or five years ( Fig. I ; Table I ). The present paper examines the causes of this and attempts to forecast future trends. The present is an opportune time for such an appraisal because very expensive apparatus and considerable reorganisation will be needed if this rate of growth continues. It is sometimes suggested that technical advances in laboratory medicine have themselves stimulated the demand for increased laboratory work. There are valid arguments for the view that this is not the case, these demands have arisen to meet existing needs which themselves stemmed from clinical dissatisfaction with alternative methods of diagnosis. They have enabled work to be done more easily, more quickly and more economically. Indeed, the financial stringency under which heads of laboratories must operate usually ensures that there is no expansion until the existing facilities are over-extended. This exponential growth of clinical chemistry is part of the similar overall growth and improvement in the quality of medical care. There are so many unresolved problems in medicine, that it is hard to see how this growth can do anything but continue unless the decision to improve the overall standard of medical care and health of the nation is rescinded.
Some general reasons for suggesting that the work of clinical chemistry departments will increase are summarised in Table 2. The management of thyroid, renal and hepatic disease, and such aspects of gastroenterology as the diagnosis of intestinal malabsorption, are examples of clinical areas in which serious dissatisfaction with other methods of diagnosis have led ultimately to the use of chemical methods which make heavy demands on the laboratory. Bedside clinical observation is often inadequate for monitoring treatment in rapidly changing clinical situations, and the widespread use of chemical methods has made a major contribution to the improved prognosis of patients in these situations. Some examples are: after major surgery, renal failure which is being treated either conservatively or by dialysis or transplantation, hepatic failure, diabetic coma. Patients needing intensive nursing care now tend to be concentrated in high dependency nut sing areas, intensive care units, coronary care units and special care baby units. The successful operation of these departments requires the services of the clinical chemistry department throughout the 24-h period. A limited range of tests is needed, and this includes blood gas analysis, pH measurements, some enzyme determinations, and electrolyte analyses on blood, urine and fistula discharges. A flexible organisation to cope with emergency situations, accuracy and speed are major desiderata.
Drug side-effects present three different problems to the Clinical Chemist.These are: I. the early detection of a toxic action, 2. the measurement of the drug or its metabolites in body fluids, 3. the identification of clinically silent enzyme abnormalities which sometimes cause abnormal drug sensitivity and serious side effects (e.g. the choline esterase deficiency which makes some individuals abnormally sensitive to suxamethonium, or the glucose-6phosphate dehydrogenase deficiency which causes abnormal sensitivity to primaquin).
The control of therapy on the basis of the results of chemical analysis has been widely practiced in connection with diabetes mellitus for more than 40 years and the developments in other fields of therapeutics and applied pharmacology have greatly increased this type of need (e.g. the treatment of hypercholesterolaemic and hyperuricaemic states).
The increasing need for screening and presymptomatic diagnosis includes a wide range of chemical work. For example: I. preoperative checks on blood chemistry, without which a surgeon might, in certain circumstances, be judged to have operated illadvisedly or even negligently; 2. the screening of neonates for inborn errors of metabolism, either because these need immediate treatment (e.g. phenylketonuria) or because they complicate the patient's subsequent medical management, (e.g, sickle cell disease), 3. screening for evidence of drug abuse, 4. presymptomatic diagnosis of diseases where early treatment is important (e.g. the identification of the 'prediabetic' state). Prognostic screening has also proved its value in the long term management of slowly progressive disorders especially where one has to begin to plan for a major change in the treatment regime when the disease reaches a certain point (e.g. the patient with progressive renal failure who will need chronic dialysis or renal transplantation).
There has been an increased awareness of the value of chemical methods of diagnosis among clinicians during the past 25 years. This arises from changes in medical faculty curricula, greater emphasis being placed on dynamic functional concepts of disease with less emphasis on static morphology and rigid taxonomy. Clinical chemists have often played a leading part in these educational developments.
Although a precise costing exercise to take all the factors into account would be very difficult, it seems likely that the increased use of specific chemical tests rather than some aspects of the traditional clinical examination could present an overall economy. Experienced clinicians are still better at history-taking than computers but chemical data sometimes give more precise diagnostic information than protracted physical examination, and should be the primary diagnostic method in such cases. The increasing use of chemical methods of diagnosis should allow the clinician to use more of his time for the aspects of clinical work which depend most on the personal and verbal interaction of the patient and h is doctor.
Some reasons for predicting a further increase in the work of clinical chemistry departments are enumerated in Table 3 . Previous experience suggests that the development of an effective treatment for malignant disease or atherosclerosis would increase the need for clinical chemical work. The need for predictive diagnosis will increase, especially in the inherited disorders. These conditions first express themselves at birth, in infancy and childhood or in later life. It is valuable to identify the affected members of the families as soon as possible so that they can be treated if treatment is available or at least advised about suitable training, employment and the genetic risk in future generations. It is common knowledge that the average age of the population is rising and that morbidity increases in the elderly, furthermore these patients often have several diseases each of which contributes to their overall disability. Effective geriatric practice necessitates the careful treatment of each component of the patient's overall illness. Thus, each elderly patient may generate more work than a younger individual who more often has a single system illness.
The present success of renal transplant programmes indicates that this type of work, which depends heavily on the application of chemical techniques in the laboratory, will continue and expand during the next decade.
The work of the clinical chemist is ultimately generated by patients, and it is pertinent to try and define exactly what it is that the clinical chemist contributes to patient-care which no one else in the diagnostic and therapeutic team of a modern hospital can. The four main lines of activity: analytical chemistry, organisation, interpretation, consultation (Table 4 ) are interrelated so that given the present and increasing volume of work, they cannot be efficiently accomplished without mechanical methods of analysis and data handling. It is essential to recruit analytical chemists of high calibre into the profession of clinical chemistry. It is an easier intellectual transition to move from a more exact science into a less exact one than to move in the opposite direction. It is the present writer's opinion that although the scientific content of medical first degree courses has improved greatly during the past 15 to 20 years, the best first degree course for the aspiring clinical chemist is usually a degree in chemistry or biochemistry, the medical content of the subject being added at a later stage. As with other aspects of education and vocational training, this is a controversial topic and the reverse view is held firmly in some quarters. Although medicine now depends heavily on basic science, the clinical chemist may be the only representative of the natural sciences on the senior staff of a hospital. His scientific credentials should be impeccable and he needs the rigorous critical approach which stems from early training in pure science. This will counteract some of the inevitable scientific inexactness of clinical practice which sometimes seems to tend to spread towards the associated disciplines.
Clinical needs put some temporal constraints about the practice of clinical chemistry. The methodology and organisation have to be able to cope with the different degrees of urgency, namely: I. results needed within the hour; 2. during the same working day; 3. the next day; 4. tests in which a delay of more than one day is acceptable between the issue of a request and the receipt of results.
Some possible approaches to the problem of enabling the clinical chemist to fulfil his multifarious functions are: I. the use of high capacity automation; 2. automatic data handling and data distribution; 3. centralisation and the development of large departments in which subspecialisation is possible; 4. employment of trained laboratory managers to relieve highly trained scientific and technical staff for scientific and consultative problems. These indivi-duals would be particularly concerned with theorganisation for the distribution of the results of laboratory tests as well as such intradepartmental administrative duties as might be delegated to them by the head of the laboratory.
The use of some or all of these methods would deal with the problem of the tests which are widely used and required in large numbers. The range of tests in this category will change and the types of tests which are at present in this category are presented in Table 5 . Some tests such as those required for the identification of poisons, or for the diagnosis of rare diseases, and chemical determinations which are inherently difficult at the time under consideration will not be suitable for large scale automation although they may well be undertaken in a central laboratory. The question of centralising laboratory work is particularly difficult and considerable discussion will have to take place between the clinicians and laboratory workers if it is to be successfully accomplished to the mutual benefit of both groups. It must be arranged in such a way that the overall service and availability of results is improved. Introducing centralisation in association with the distribution of laboratory results directly to the wards and outpatient clinics by teleprinter terminals, would overcome one of the main difficulties in many hospitals (namely delay between the analysis and the arrival of the result at its final destination) and should commend such a scheme to clinicians. Centralisation and the development of large departments would improve the range of consultation available for the clinicians because subspecialties within clinical biochemistry could be developed more easily. Laboratory tests evolve by the interplay of laboratory and clinical work, and their evolution from the stage of clinical dissatisfaction to the stage of an established and universally accepted test are shown in Fig. 2 . It is important to avoid overpublicising a new test during its initial trial and before its place in the diagnostic repertoire is established. If this is not done, the test may be used in inappropriate circumstances and it may get an undeservedly bad reputation for this reason. Once the test has proved its worth and been taken into general use, early consideration should be given to automating it. When this has been achieved, it is important that the whole pattern of its use is re-evaluated so that the greatly increased throughput of the automatic method can be fully exploited. It is also important that the clinicians are not only educated in the use of the particular test concerned, but re-educated from the point of view of their use of other tests which the new one may replace. Laboratory departments and clinical practice should not become cluttered up with cumbersome and inexact procedures when more efficient methods are available. Some likely future developments in the work of clinical chemistry departments are summarised in Table 6 . Some of these activities are already in progress, others will require the acquisition of expertise in techniques that have not previously come within the clinical chemist's sphere of activity, for example: tissue culture, the analysis of blood 99 cells and tissue biopsies, immunochemical and radiochemical methods, the more extended use of enzyme kinetics, and the use of chemical methods for the identification of bacteria.
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